Clinical Trials List
Protocol NumberSC291-101
Completed
2024-12-01 - 2024-12-02
Phase I
Recruiting2
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ming-Yu Lien Division of Hematology & Oncology
- 鄭富銘 Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- 王幸婷 Division of Hematology & Oncology
- Tzu-Ting Chen Division of Hematology & Oncology
- Wei-Ching Lin Division of Radiology
- Ching-Chan Lin Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chien-Chin Lin Division of Others -
- Ming-Che Kuo Division of Neurology
- YAO CHI-YUAN Division of Others -
- CHENG-HONG TSAI Division of Hematology & Oncology
- 柯紀綸 Division of Nuclear Medicine
- 田豐銘 Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- 劉高郎 Division of Radiology
- 林明恩 Division of Hematology & Oncology
- Tai-Chung Huang Division of Hematology & Oncology
- Wen-Chien Chou Division of Others -
- - - Division of Hematology & Oncology
- 施怡倫 Division of Radiology
- 李思慧 Division of Family Medicine
- 范淞斌 Division of Neurology
- WEI-LI MA Division of Hematology & Oncology
- 徐思淳 Division of Others
- Chieh-Lung Cheng Division of Hematology & Oncology
- 袁章祖 Division of Others
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
9 participants
-
Global
57 participants
